Drug Shortage Report for OMNIPAQUE 300

Last updated on 2024-02-15 History
Report ID 217411
Drug Identification Number 02172747
Brand name OMNIPAQUE 300
Common or Proper name iohexol injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IOHEXOL
Strength(s) 647MG
Dosage form(s) SOLUTION
Route of administration RECTAL ORAL INTRA-ARTICULAR INTRAVASCULAR SUBARACHNOIDAL
Packaging size 20 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Demand increase for the drug.
Anticipated start date 2024-02-12
Actual start date 2024-02-13
Estimated end date 2024-02-20
Actual end date 2024-02-14
Shortage status Resolved
Updated date 2024-02-15
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2024-02-15 English Compare
v11 2024-02-14 French Compare
v10 2024-02-14 English Compare
v9 2024-02-14 English Compare
v8 2024-02-13 French Compare
v7 2024-02-13 English Compare
v6 2024-02-13 English Compare
v5 2024-02-09 French Compare
v4 2024-02-09 English Compare
v3 2024-02-08 English Compare
v2 2024-01-26 French Compare
v1 2024-01-26 English Compare

Showing 1 to 12 of 12